Magnetic resonance imaging to measure therapeutic response using an orthotopic model of human pancreatic cancer

Pancreas

Volumn 21, Issue 1, 2000, Pages 69-76

  He, Zhanquan ^a   Evelhoch, Jeffrey L ^b   Mohammad, Ramzi M ^b   Adsay, N Volkan ^b   Pettit, George R ^c   Vaitkevicius, Vanutis K ^b   Sarkar, Fazlul H ^b  

^a WAYNE STATE UNIVERSITY   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ARIZONA STATE UNIVERSITY   (United States)

Author keywords

Auristatin PE; Chemotherapy; Orthotopic tumor growth curve; T1 T2

Indexed keywords

AURISTATIN PE; GEMCITABINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS BIOPSY; PANCREAS CANCER; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR MODEL; TUMOR VOLUME;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MICE; MICE, SCID; OLIGOPEPTIDES; PANCREAS; PANCREATIC NEOPLASMS; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0033934419     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-200007000-00054     Document Type: Article

References (21)

1. Parker SL, Davis KJ, Wingo PA, Ries LA, Heath CW. Cancer statistics by race and ethnicity. CA Cancer J Clin 1998;48:31-48.
2. Gudjonnson B. Carcinoma of the pancreas: 50 years of surgery. Cancer 1987;60:2284-303.
3. Warshaw AW, Fernandez-del Castillo C. Pancreatic carcinoma. N Engl J Med 1992;326:455-65.
4. Lillemore KD. Current management of pancreatic carcinoma. Ann Surg 1995;221:133-48.
5. Casper ES, Kelson DP. Adenocarcinoma of the pancreas: Overview of workup and management. Adv Oncol 1995;11:17-22.
6. Kelly DM, Benjamin IS. Pancreatic carcinoma. Ann Oncol 1995; 6:19-28.
7. Hertel LW, Boder GB, Kroin JS, Rinzel SM, Poore GA, Todd GC. Evaluation of the anti-tumor activity of gemcitabine (2′, 2′-difluoro-2′-deoxycytidine). Cancer Res 1990;50:4417-22.
8. Grindey GB, Hertel LW, Plunkett W. Cytotoxicity and anti-tumor activity of 2′, 2′-difluoro-2′-deoxycytidine (gemcitabine). Cancer Invest 1990;8:313-8.
9. Rothenberg ML, Moore MJ, Cripps MC, et al. A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer. Ann Oncol 1996;7:347-53.
10. Pettit GR, Kamano Y, Herald CL, et al. The isolation and structure of a remarkable marine animal antineoplastic constituent: dolastatin 10. J Am Chem Soc 1987;109:6883-94.
11. Pettit GR. The dolastatins. In: Herz W, Kirby GW, Moore RE, Steglich W, Tamm C, eds. Progress in the chemistry of organic natural products. New York: Springer, 1997:2-63.
12. Bai R, Roach MC, Jayaram SK, et al. Differential effects of active isomers, segments, and analogs of dolastatin 10 on ligand interactions with tubulin. Correlation with cytotoxicity. Biochem Pharmacol 1993;45:1503-15.
13. Pettit GR, Srirangam JK, Barkoczy J. et al. Antineoplastic agents 337. Synthesis of dolastatin 10 structural modifications. Anticancer Drug Des 1995;10:529-44.
14. Fogh J, Orfeo T, Tiso J, Sharkey FE, Fogh JM, Daniels WP. Twenty-three new human tumor lines established in nude mice. Exp Cell Biol 1980;48:229-39.
15. Sordat BC, Ueyama Y, Fogh J. Metastasis of tumor xenografts in the nude mouse. In: Fogh J, Gilovanella BC, eds. The nude mouse in experimental and clinical research, vol. 2. New York: Academic Press, 1982:95-143.
16. Mohammad RM, Al-Katib A, Pettit GR, Vaitkevicius VK, Joshi U, Adsay V, Majumdar APN, Sarkar FH. An orthotopic model of human pancreatic cancer in severe combined immunodeficient mice: potential application for preclinical studies. Clin Cancer Res 1998;4:887-94.
17. Mazurchuk R, Glaves D, Raghavan D. Magnetic resonance imaging of response to chemotherapy in orthotopic xenografts of human bladder cancer. Clin Cancer Res 1997;3:1635-41.
18. Westbrook C, Kaut C. Vascular and cardiac imaging. In: MRI in practice. Blackwell Scientific Publications, 1993:175-203.
19. Westbrook C, Kaut C. Image Weighting and Contrast. In: MRI in Practice. Blackwell Scientific Publications, 1993:17-46.
20. Wang Y, Grimm RC, Felmlee JP, Riederer SJ, Ehman RL. Algorithms for extracting motion information from navigator echoes. Magn Reson Med 1996;36:117-23.
21. Kyriakos WE, Panych LP, Zientara GP, Jolesz FA. Implementation of a reduced field-of-view method for dynamic MR imaging using navigator echoes. J Magn Reson Imag 1997;7:376-81.